China · Delayed Price · Currency is CNY Hinova Pharmaceuticals Statistics
Total Valuation
SHA:688302 has a market cap or net worth of CNY 4.22 billion. The enterprise value is 3.41 billion.
| Market Cap | 4.22B |
| Enterprise Value | 3.41B |
Important Dates
The next confirmed earnings date is Saturday, April 25, 2026.
| Earnings Date | Apr 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688302 has 99.02 million shares outstanding. The number of shares has decreased by -0.20% in one year.
| Current Share Class | 99.02M |
| Shares Outstanding | 99.02M |
| Shares Change (YoY) | -0.20% |
| Shares Change (QoQ) | +0.86% |
| Owned by Insiders (%) | 20.16% |
| Owned by Institutions (%) | 19.73% |
| Float | 70.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 204.03 |
| PB Ratio | 3.83 |
| P/TBV Ratio | 3.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -24.93 |
| EV / Sales | 164.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -11.92% and return on invested capital (ROIC) is -7.05%.
| Return on Equity (ROE) | -11.92% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -7.05% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 3.71% |
| Revenue Per Employee | 118,815 |
| Profits Per Employee | -785,560 |
| Employee Count | 174 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SHA:688302 has paid 3,100 in taxes.
| Income Tax | 3,100 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.60% in the last 52 weeks. The beta is -0.08, so SHA:688302's price volatility has been lower than the market average.
| Beta (5Y) | -0.08 |
| 52-Week Price Change | +15.60% |
| 50-Day Moving Average | 48.09 |
| 200-Day Moving Average | 51.50 |
| Relative Strength Index (RSI) | 38.10 |
| Average Volume (20 Days) | 1,044,124 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688302 had revenue of CNY 20.67 million and -136.69 million in losses. Loss per share was -1.38.
| Revenue | 20.67M |
| Gross Profit | 20.67M |
| Operating Income | -135.79M |
| Pretax Income | -136.68M |
| Net Income | -136.69M |
| EBITDA | -133.72M |
| EBIT | -135.79M |
| Loss Per Share | -1.38 |
Balance Sheet
The company has 917.05 million in cash and 106.67 million in debt, with a net cash position of 810.38 million or 8.18 per share.
| Cash & Cash Equivalents | 917.05M |
| Total Debt | 106.67M |
| Net Cash | 810.38M |
| Net Cash Per Share | 8.18 |
| Equity (Book Value) | 1.10B |
| Book Value Per Share | 11.12 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -656.84% |
| Pretax Margin | -661.15% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SHA:688302 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.20% |
| Shareholder Yield | 0.20% |
| Earnings Yield | -3.24% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |